Literature DB >> 19609588

Comment on "effects of adipocyte-secreted factors on cell cycle progression in HT29 cells" published by Eur J Nutr.

Jiezhong Chen, Xu-Feng Huang.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19609588     DOI： 10.1007/s00394-009-0040-z

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN： 1436-6207            Impact factor:   5.614


× No keyword cloud information.
  8 in total

1.  Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells.

Authors:  Kerstin Schnäbele; Silvia Roser; Gerhard Rechkemmer; Hans Hauner; Thomas Skurk
Journal:  Eur J Nutr       Date:  2009-01-23       Impact factor: 5.614

Review 2.  Is Src the key to understanding metastasis and developing new treatments for colon cancer?

Authors:  Jiezhong Chen
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-05-13

3.  Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma.

Authors:  Sung-Shin Park; Yong-Nyun Kim; Yoon Kyung Jeon; Young A Kim; Ji Eun Kim; Heejung Kim; Chul Woo Kim
Journal:  Cancer Chemother Pharmacol       Date:  2005-05-10       Impact factor: 3.333

4.  Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways.

Authors:  Tamara Jaffe; Betty Schwartz
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

Review 5.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

6.  Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.

Authors:  Yiwei Li; Fazlul H Sarkar
Journal:  Clin Cancer Res       Date:  2002-07       Impact factor: 12.531

Review 7.  Obesity, the PI3K/Akt signal pathway and colon cancer.

Authors:  X-F Huang; J-Z Chen
Journal:  Obes Rev       Date:  2009-06-12       Impact factor: 9.213

Review 8.  Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia.

Authors:  Jiezhong Chen; Nigel A J McMillan
Journal:  Cancer Biol Ther       Date:  2007-11-03       Impact factor: 4.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.